The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome

The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome
复制标题

DOI:
10.1016/j.jhep.2009.04.017
复制
发表时间:
2009-09-01
影响因子:
25.7
通讯作者:
Salerno, Francesco
Salerno, Francesco
中科院分区:
医学1区
文献类型:
--
作者:
Cazzaniga, Massimo;Dionigi, Elena;Salerno, Francesco

文献摘要

被引文献

相似文献

背景/目的:有证据表明,全身炎症反应综合征(SIRS)是导致哮喘患者预后不良的原因之一。我们研究了141例连续入院的三级转诊中心评估SIRS的患病率及其与住院outcome.Methods的关系:SIRS的存在进行了评估入院和住院期间。主要临床结局为死亡和门脉高压相关并发症的发生。结果:39例患者符合SIRS标准。141例患者中有20例(14.1%)在入院时出现SIRS,而121例患者中有19例(15.7%)在住院期间出现SIRS。SIRS与入院时细菌感染相关(P = 0.02),黄疸(p = 0.011),高血清肌酐水平(p = 0.04),高血清胆红素水平(p = 0.002),高国际标准化比率(p = 0.046)、高终末期肝病模型(MELD)评分(p = 0.001)和高SOFA评分(p = 0.003)。在14 ± 8天的随访期间,16例患者死亡(11%),7例发生门静脉高压相关出血(5%),16例肝性脑病(11%)和5例肝肾综合征1型(3.5%)。SIRS与死亡(p < 0.001)和门脉高压相关并发症(p < 0.001)相关。在多变量分析中,SIRS和MELD独立与death.Conclusions:SIRS经常发生在晚期肝硬化患者,并与预后不良。(C)2009年欧洲肝脏研究协会。Elsevier B. V.出版,保留所有权利。
Background/Aims: Some evidence suggests that the systemic inflammatory response syndrome (SIRS) contributes to the poor outcome of cirrhotic patients. We studied 141 cirrhotic patients consecutively admitted to a tertiary referral centre assessing prevalence of SIRS and its relationship with in-hospital outcome.Methods: Presence of SIRS was assessed on admission and during hospital stay. Main clinical outcomes were death and development of portal hypertension-related complications.Results: Thirty-nine patients met SIRS criteria. SIRS was present on admission in 20 of 141 patients (14.1%), whereas it occurred during hospital stay in 19 of 121 (15.7%). SIRS was correlated with bacterial infection at admission (P = 0.02), jaundice (p = 0.011), high serum creatinine levels (p = 0.04), high serum bilirubin levels (p = 0.002), high international normalized ratio (p = 0.046), high model of end-stage liver disease (MELD) score (p = 0.001), and high SOFA score (p = 0.003). During a follow-up of 14 +/- 8 days, 16 patients died (11%), 7 developed portal hypertension-related bleeding (5%), 16 hepatic encephalopathy (11%), and 5 hepatorenal syndrome type-1 (3.5%). SIRS was correlated both to death (p < 0.001) and to portal hypertension-related complications (p < 0.001). On multivariate analysis, SIRS and MELD were independently associated with death.Conclusions:SIRS frequently occurs in patients with advanced cirrhosis and is associated with a poor outcome. (C) 2009 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.